American Association for the Advancement of Science, Science Translational Medicine, 616(13), 2021
DOI: 10.1126/scitranslmed.abj5413
Full text: Unavailable
Bispecific antibodies targeting multiple regions of the SARS-CoV-2 spike protein comparably neutralize variants of concern and wild-type virus.